A carregar...

Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma

Ibrutinib has clear efficacy for activated B-cell-like diffuse large B cell lymphoma (ABC-DLBCL) in previous clinical researches. However, the resistance of Ibrutinib has limited its therapeutic benefit and the potential mechanism remains unclear. This study was aimed to identify potential candidate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med Oncol
Main Authors: Li, Jiazheng, Huang, Yan, Zhang, Yun, Wen, Jingjing, Chen, Yanxin, Wang, Lingyan, Jiang, Peifang, Hu, Jianda
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904539/
https://ncbi.nlm.nih.gov/pubmed/33629212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-021-01470-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!